Resuscitec
1 known investors
Resuscitec develops CARL, a therapy and device system for controlled reperfusion during extracorporeal cardiopulmonary resuscitation (ECPR) that monitors patient-specific vital parameters after cardiac arrest to improve neurologically intact survival. It serves clinical users and hospitals, offering clinical support and training through the CARL Academy.
HardwareHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Resuscitec do?
- Resuscitec develops CARL, a therapy and device system for controlled reperfusion during extracorporeal cardiopulmonary resuscitation (ECPR) that monitors patient-specific vital parameters after cardiac arrest to improve neurologically intact survival. It serves clinical users and hospitals, offering clinical support and training through the CARL Academy.
- Who are Resuscitec's investors?
- Resuscitec's investors include kineo finance.